Giovanni Targher
University of Verona · 898 works · 71,872 citations · h-index 127
Top works
- Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
- NAFLD: A multisystem disease
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
- Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients
- Nonalcoholic Fatty Liver Disease and Risk of Future Cardiovascular Events Among Type 2 Diabetic Patients
- Relation Between Red Blood Cell Distribution Width and Inflammatory Biomarkers in a Large Cohort of Unselected Outpatients
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
- Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Cardiovascular Events in Type 2 Diabetic Patients
- Non-alcoholic fatty liver disease and increased risk of cardiovascular disease
- Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases
- HOMA-Estimated Insulin Resistance Is an Independent Predictor of Cardiovascular Disease in Type 2 Diabetic Subjects
- The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
- Relations Between Carotid Artery Wall Thickness and Liver Histology in Subjects With Nonalcoholic Fatty Liver Disease
- The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study
- Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?
- Relation of Nonalcoholic Hepatic Steatosis to Early Carotid Atherosclerosis in Healthy Men
- COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies